DRUGS MADE IN AMERICA ACQUISITION II CORP.
Balance Sheet
| Line Item | FY2025 | FY2024 |
|---|---|---|
| Assets | ||
| Cash & Equivalents | $223 | $17.0K |
| Accounts Receivable | — | — |
| Inventory | — | — |
| Total Current Assets | $26.0K | $59.6K |
| Property, Plant & Equipment | — | — |
| Goodwill | — | — |
| Intangible Assets (Excl. Goodwill) | — | — |
| Total Assets | $505.0M | $138.1K |
| Liabilities | ||
| Accounts Payable | $99.4K | — |
| Total Current Liabilities | $300.9K | $254.8K |
| Long-Term Debt | — | — |
| Total Liabilities | $17.8M | $254.8K |
| Stockholders' Equity | ||
| Retained Earnings | $-17.8M | $-151.7K |
| Total Stockholders' Equity | $-17.8M | $-116.7K |